MLP Care has successfully optimized its hospital portfolio over the past five years by divesting low-margin facilities, integrating high-performing hospitals, and restructuring operations. These factors have strengthened operational efficiency per hospital and per bed since 2022. Additionally, through effective cash flow management and a strategic shift away from FX-denominated debt, MLP Care has lowered its net debt/EBITDA ratio from 2.7x in 2019 to 0.4x in 9M24. While the company has not yet d...
MLP Care has effectively restructured its hospital portfolio over the past four years and implemented cost optimization measures, resulting in a 10% EBITDA CAGR in USD terms from 2019 to 2023. As private health insurance and foreign medical tourism revenues continued to recover, the proportion of revenue exposed to the social security system decreased to 14% by 2023. Concurrently, net debt decreased from USD348m in 2019 to USD110m in 2023, with 70% attributed to lease liabilities. Anticipating a...
Including Turkiye Sigorta and MLP Care to our model portfolio, while removing Alarko Holding: We are including Turkiye Sigorta and MLP Care to our model portfolio while removing Alarko Holding. Turkiye Sigorta: Turkiye Sigorta is a beneficiary from the rise in deposit rates. The company has TL21bn AUM as of Mar’23 and 41% of this was TL bank deposits. On the other hand, FX long position (excl. technical reserves) was TL3.4bn (USD176m) in 1Q23 and we estimate the company to book a significant FX...
We include new macro forecasts, revise our target price up to TL116 (previously TL105), and maintain our BUY rating. We believe MLP Care has successfully executed a period of deleveraging and will be able to withstand a volatile inflation and interest rate environment. The addition of new hospitals and effective cost management should help to secure growth in real terms. MLP Care trades at a 2023E P/E of 10.8x, with a 4/% discount to its international peers. MLP Care continues with buybacks. It ...
Excluding MLP Care from our model portfolio: MLP Care has outperformed BIST-100 by 25% and returned 47% in absolute terms since its inclusion to our model portfolio on Sep 6, 2022. Following the strong outperformance, we remove the stock from our model portfolio, while we continue to favor growth momentum and deleveraging strategy of MLP Care and maintain our BUY rating, MLP Care has effectively reduced financial leverage, thanks to low capex and asset light model strategy and divestiture of l...
Dubai toll road operator Salik’s forthcoming listing is attracting significant investor attention, given the firm’s high local profile, its enviable profitability metrics and its commitment to distributing 100% of profits to shareholders. The AED2.00 fixed subscription price gives clarity and positions the shares directly at yield-seeking investors. We take a look at the firm’s business model, growth potential and risks to the investment case, via 12 key points of interest for potential inves...
We revise our estimates upwards to reflect inflationary trends in Turkey, the better-than-expected foreign medical tourism (FMT) revenues, the company’s lower leverage thanks to improved FCF generation and the divestiture of four hospitals. We also lift our target price to TL63.3 (from TL39.5 previously) and maintain our BUY rating. We see the potential addition of value-accretive hospitals outside Turkey and a sustained improvement in working capital as the key catalysts. While the company has ...
Including MLP Care to our model portfolio: We are including MLP Care to our model portfolio. MLP Care has underperformed BIST-100 by 28% in the 12M period. We revise our estimates upwards to reflect inflationary trends in Turkey, the better-than-expected foreign medical tourism (FMT) revenues, the company’s lower leverage thanks to improved FCF generation and the divestiture of four hospitals. We also lift our target price to TL63.3 (from TL39.5 previously) and maintain our BUY rating. We see th...
We are discontinuing our coverage of the stocks listed below, with immediate effect. We caution against using the forecasts, ratings and price target guidance issued previously on these stocks. Atlantic Grupa DO&CO DP Eurasia Energa Medicalgorithmics MLP Care NIS Nostrum Oil & Gas Podravka SIF 1 Banat-Crisana SIF 2 Moldova SIF 3 Transilvania SIF 4 Muntenia SIF 5 Oltenia Sphera Stock Spirits
The general evaluation of MLP SAGLIK HIZMETLERI (TR), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date December 24, 2021, the closing price was T...
HEADLINES: • Polish banks: can pay out up to 100% of 2021E net profit as dividends • PZU: insurance sector can pay up to 100% of 2020 net profit and up to 50% of 2021E net profit NEUTRAL • Inter Cars: all-time high sales (again) - PLN 1.2bn (+39% yoy) in November POSITIVE • Romania macro: finance minister says 2022 budget will not include new taxes • Electrica: shareholders reject acquisition of 29MW PV plant NEGATIVE • Richter: licenses denosumab biosimilar to Hikma for US market POSITIVE WO...
EME Equity Market – November 2021 Market performance – most markets down, with Czech PX Index (+3.0%) the exception. The MSCI EM Europe Index lost 8.9% in EUR terms and 10.7% in USD in November. Prague’s PX Index added 3.0% in EUR terms and 2.3% in local currency, followed by the Romanian BET Index, which declined 3.2% in both EUR and RON terms. Greece’s ASE Index declined by 3.4% in EUR terms, while Hungary’s BUX Index declined by 6.2% in EUR and 5.0% in HUF. The Russian MOEX Index declined 8.6...
HEADLINES: • Komercijalna Banka: too expensive now (downgraded to SELL) • NLB Banka: good story, unattractive price (downgraded to SELL) • PKO BP: delivers solid 3Q21 and marks 12% ROE, even without positive impact of rising interest rates POSITIVE • OTP Bank: 3Q21 results solid, but not exceeding high expectations NEUTRAL • Dino: single-digit miss in 3Q21 NEGATIVE • MOL: 3Q21 results - strong result, beating expectations mildly • Turkcell: 3Q21 results - 9% NI beat, minor guidance upgrade P...
EME Equity Market – August 2021 Market performance - The Hungarian BUX Index gained 9.8% in EUR terms. The MSCI EM Europe Index rose 5.1% in EUR terms and 4.6% in USD terms. The best-performing equity index was the BUX, which added 9.8% in EUR terms and 6.9% in the local currency (LCU). The ISE30 Index advanced 7.7% in EUR terms and 5.8% in LCU, while Prague’s PX Index gained 6.5% in EUR terms and 6.2% in LCU. The Polish benchmark WIG20 Index added 6.1% in EUR terms and 5.1% in LCU, followed by ...
HEADLINES: • Tekfen Holding: 2Q21 results - guidance upgraded, despite 19% NI miss POSITIVE • Turkcell: 2Q21 results - broadly in line, FY21E guidance upgrade unlikely to move the consensus • BIM: 2Q21 a notch below expectations against tough comps NEUTRAL • X5: 2Q21 in line with expectations; EBITDA margin hike NEUTRAL • MLP Care: net profit beat on deferred tax gain NEUTRAL • O2 Czech Republic: reports solid 2Q21 results, with EBITDA up 6% yoy, 2% above the consensus NEUTRAL • Romgaz: 2Q21 re...
HEADLINES: • Turkish Airlines: 2Q21 - strong cargo pricing the key driver of revenues, beat on EBIT and EBITDA POSITIVE • Isbank: 2Q21 highlights - quality disappoints • Enerjisa Enerji: 2Q21 results review - another strong quarter, 2021E guidance hiked POSITIVE • Magyar Telekom: strong 2Q21 results, with EBITDA up 6% yoy; 2021E EBITDAaL guidance upgrade POSITIVE • Aselsan: 2Q21 results - strong beat, driven by peaking EBITDA margins POSITIVE • Addiko Bank: 2Q21 results review - lower on Other...
HEADLINES: • Astarta Holding: sweet rebirth at the peak of the cycle (HOLD - initiation of coverage) • Isbank: 1Q21 results review - beats consensus, but reports weakest comprehensive income among peers • Richter: 1Q21 misses consensus on CIS and rebounding opex • Turkish Airlines: UK and France add Turkey to travel red list NEGATIVE • Kety: 1Q21 conference call takeaways POSITIVE • MLP Care: takeaways from the 1Q20 earnings call NEUTRAL • Russia macro: inflation declines to 5.5% yoy in April...
HEADLINES: • Kety: strong stuff (40%+)... but we want more (stays BUY) • OTP Bank: strong start to the year, as 1Q21 results beat on provision charges POSITIVE • Raiffeisen Int: solid 1Q21 on low provision charges, but FY21E outlook sees much higher COR NEUTRAL • Logo Yazilim: 1Q21 results - strong execution, with a 15% EBITDA/NI beat POSITIVE • SOK Marketler Ticaret: 1Q21 beat, on strong sales POSITIVE • MLP Care: 1Q21 - net profit beats on operating FX gains POSITIVE • Ulker: 1Q21 results ...
EME Equity Market – March 2021 Market performance – Greek, Romanian and Russian equities performed the best in March. The MSCI EM Europe Index gained 4.5% in EUR terms and 1.6% in USD terms. The best-performing index was the Greek ASE (+9.2%), followed by the Romanian BET, which gained 8.7% in EUR terms and 9.7% in RON. The MOEX followed, advancing 7.6% in EUR terms and 5.8% in RUB. The PX Index, the Czech benchmark, gained 3.4% in EUR terms and 3.1% in CZK; while the Hungarian BUX Index gained ...
HEADLINES: • Polish banks: ZBP publishes slightly different estimates for CHF mortgage portfolio conversion costs • TeraPlast: proposes RON 0.13 special dividend, 24% dividend yield on 8 March closing price • Nuclearelectrica: strategy for continuing Units 3 and 4 project • Inter Cars: February sales +22% yoy - both foreign and domestic markets strong again POSITIVE • BIM: takeaways from the 4Q call NEUTRAL • Rostelecom: key takeaways from the 4Q20 earnings call NEUTRAL • MLP Care: conference...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.